MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-024-12857-8

Медицинская библиотека · BMC cancer · 2024

Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma.

Dong Yan, Chen Xinyi, Yang Shen, Fu Yilong, Wang Liangyu, Gao Xueping, Chen Di, Xu Lixia

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Hepatocellular carcinoma (HCC), a prevalent primary malignant tumor, is notorious for its high mortality rate. Despite advancements in HCC treatment, patient outcomes remain suboptimal. This study endeavors to assess the potential prognostic significance of POLH-AS1 in HCC.

METHODS

In this research, we gathered RNA-Seq information from individuals with HCC in The Cancer Genome Atlas (TCGA). We analyzed the levels of POLH-AS1 expression in both HCC cells and tissues using statistical tests. Additionally, we examined various prognostic factors in HCC using advanced methodologies. Furthermore, we employed Spearman's rank correlation analysis to examine the association between POLH-AS1 expression and the tumor's immune microenvironment. Finally, the functional roles of POLH-AS1 in HCC were validated in two HCC cell lines (HEP3B and HEPG2).

RESULTS

Our analysis revealed elevated POLH-AS1 expression across various cancers, including HCC, with heightened expression correlating with HCC progression. Notably, POLH-AS1 expression emerged as a potential biomarker for HCC patient survival and prognosis. Mechanistically, we identified the involvement of POLH-AS1 in tumorigenesis pathways such as herpes simplex virus 1 infection, interactions with neuroactive receptors, and the cAMP signaling pathway. Lastly, inhibition of POLH-AS1 was discovered to hinder the proliferation, invasion and migration of HEP3B and HEPG2 HCC cells.

CONCLUSIONS

POLH-AS1 emerges as a promising prognostic biomarker and therapeutic target for HCC, offering potential avenues for enhanced patient management and treatment strategies.

Для цитирования: Dong Yan, Chen Xinyi, Yang Shen, Fu Yilong, Wang Liangyu, Gao Xueping, Chen Di, Xu Lixia. Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma.. BMC cancer. 2024. DOI: 10.1186/s12885-024-12857-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.